Matched cohort study on the efficacy of tocilizumab in patients with COVID-19

BACKGROUND: Tocilizumab has been proposed as a treatment for the new disease COVID-19, however, there is not enough scientific evidence to support this treatment. The objective of this study is to analyze whether the use of tocilizumab is associated with respiratory improvement and a shorter time to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Molinero, Alejandro, Pérez-López, Carlos, Gálvez-Barrón, César, Miñarro, Antonio, Macho, Oscar, López, Gabriela F., Robles, Maria Teresa, Dapena, Maria Dolores, Martínez, Sergi, Rodríguez, Ezequiel, Pérez, Isabel Collado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784546/
https://www.ncbi.nlm.nih.gov/pubmed/33426262
http://dx.doi.org/10.1016/j.onehlt.2021.100214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784546/
https://www.ncbi.nlm.nih.gov/pubmed/33426262
http://dx.doi.org/10.1016/j.onehlt.2021.100214

Ejemplares similares